News   /   Reports

Sputnik-V vaccine 91.6% effective against symptomatic COVID-19

Bianca Rahimi

Press TV, London

Russia’s Sputnik V vaccine is more than 91% effective against COVID-19. The news was published Tuesday in The Lancet, a British Medical Journal.

After the announcement, German Chancellor Angela Merkel said that every vaccine is welcome in the European Union. The bloc’s vaccine rollout is lagging behind the UK and the US, and desperate and disappointed member states, including Hungary, are looking elsewhere for supplies.

Armenia, Belarus and Serbia have already got Sputnik V -- European countries which are not EU members and say they were losing out waiting for the Covax program, which was supposed to make vaccines available to everyone, to deliver.

Countries hard-hit by Western sanctions have also approved Sputnik. Venezuela has already received its first shipment and Iran’s first batch is expected any day now.

Russia has donated 5,000 doses to the Palestinians in the occupied territories as well.

The World Health organization says to end the COVID-19 pandemic, it has to be ended for everyone, everywhere. Nonetheless, rich countries are hoarding and rolling out vaccines while the least-developed nations watch and wait. It may take years for the poorest to get the job.


Press TV’s website can also be accessed at the following alternate addresses:

www.presstv.ir

SHARE THIS ARTICLE
Press TV News Roku